Bulk sample;
- Returned excellent results despite the plant not being optimised for Epanko material.
- Testwork currently being conducted on various regrind mills for small flake sizes (<100 mesh) to increase purity levels by flotation to further enhance.
- Cost and operating risk trade off assessed in light of increased operating risk of extra flotation steps against proven upgrading and established purifying methods at industrial scale.
- Robust testwork at an industrial scale lowers design risk and optimises equipment selection.
“Epanko has the advantage of flexibility due to high in-situ grade and flake size distribution”. The graph on slide 12 is well worth checking out. Keep in mind that circle will grow by 2-3-? Times once the new drilling results are announced.
Maybe KNL is taking a swipe at the market; “Banks won’t lend without realistic pricing and offtake partners”.
- Kibaran has made no “heroic” pricing assumptions in base case basket pricing assumptions.
- Realistic pricing has been used without further value capture of value added products (i.e. spherical graphite).
- Offtake is essential given there is no transparent intermediate market with acceptable payabilities for seaborne spherical graphite feedstock.
- Epanko base case pricing does not include value capture for sales into high growth markets such as spherical and expandable graphite.
Funding;
- Mandated debt finance providers – KfW-IPEX Bank + Nedbank. (KfW-IPEX Bank + Nedbank are happy with KNL using their name, on a regular basis! Sounds like funding is in the bag).
- Forums
- ASX - By Stock
- EGR
- Ann: Investor Presentation
Ann: Investor Presentation, page-9
Featured News
Add EGR (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.33M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 7.9¢ | $89.14K | 1.114M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15601 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 389459 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15601 | 0.080 |
1 | 102749 | 0.079 |
3 | 20487 | 0.077 |
4 | 53723 | 0.076 |
4 | 111118 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 389459 | 2 |
0.088 | 42000 | 1 |
0.089 | 9000 | 1 |
0.090 | 153955 | 3 |
0.091 | 25028 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
EGR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online